Urine congophilia associated with preeclampsia does not persist 6-months postpartum

Placenta. 2024 Mar 6:147:52-58. doi: 10.1016/j.placenta.2024.01.013. Epub 2024 Jan 26.

Abstract

Introduction: Preeclampsia is a common hypertensive disorder of pregnancy. Several studies have demonstrated that protein aggregates, detected through urine congophilia, is associated with preeclampsia; however, it has yet to be investigated whether urine congophilia remains postpartum in these women. In this study, we aimed to augment prior studies and determine whether urine congophilia is present postpartum.

Methods: Women were recruited from Lyell McEwin Hospital, South Australia. Urine samples were collected during pregnancy and 6-months postpartum from women with non-preeclampsia pregnancies (n = 48) and women with pregnancies complicated by preeclampsia (n = 42). A Congo Red Dot blot test, total protein and creatinine levels from urine, as well as serum Soluble fms-like tyrosine kinase 1 to placental growth factor ratio (sFlt-1:PlGF), were assessed and correlated.

Results: Preeclamptic women exhibited increased urine congophilia (P < 0.01), sFlt-1:PlGF ratio (P < 0.0001) and total protein (P < 0.01) during pregnancy; with a positive correlation between urine congophilia and total protein across the entire cohort (P < 0.0001). Although urine congophilia was no longer detected 6-months postpartum in preeclamptic women, total protein remained elevated (P < 0.05). sFlt-1:PlGF ratio during pregnancy was positively correlated with congophilia across the cohort (P = 0.0007). Serum creatinine was also higher in preeclamptic women during pregnancy (P < 0.001).

Discussion: These results support that urine congophilia is significantly elevated in pregnancies complicated with preeclampsia and show that it does not continue postpartum, although larger cohort studies are needed to determine its feasibility as a diagnostic marker.

Keywords: Congo red; Obstetrics; Placenta: Amyloid; Pregnancy; Protein aggregates; Proteinuria.

MeSH terms

  • Biomarkers
  • Cohort Studies
  • Female
  • Humans
  • Hypertension*
  • Placenta Growth Factor
  • Postpartum Period
  • Pre-Eclampsia* / metabolism
  • Pregnancy
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism

Substances

  • Placenta Growth Factor
  • Vascular Endothelial Growth Factor Receptor-1
  • Biomarkers